Anna Magdalena Schessl

After completing my Master’s in Biochemistry at the Technical University of Munich, I joined the Department of Applied Tumor Biology in 2023. My doctoral research focuses on exploring epigenetic treatment strategies for colorectal cancer, particularly Lynch syndrome-associated and microsatellite-stable BRAF-mutated tumors. Specifically, I investigate the therapeutic potential of the DNA methyltransferase inhibitor 5-Aza-2’-deoxycytidine (DAC) to reverse tumor-associated epigenetic alterations and induce durable anti-tumor responses. By combining molecular and functional analyses in in vitro and in vivo models, my research aims to contribute to the development of novel therapeutic and preventive approaches for colorectal cancer.

Projects

← Back to the team